{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:54:46Z","timestamp":1776329686759,"version":"3.50.1"},"reference-count":15,"publisher":"Baskent University","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.6002\/ect.2020.0437","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T08:08:50Z","timestamp":1610698130000},"page":"77-79","source":"Crossref","is-referenced-by-count":1,"title":["Small Intestine Posttransplant Lymphoproliferative Disorder in a Kidney Transplant Recipient: A Case Report"],"prefix":"10.6002","volume":"19","author":[{"given":"Danilo","family":"Radunovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Dapcevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Prelevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Tomovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Ratkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolina","family":"Basic Jukic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Abe T, Ichimaru N, Kokado Y, et al. Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years. Int J Urol. 2010;17(1):48-54. doi:10.1111\/j.1442-2042.2009.02405.x","DOI":"10.1111\/j.1442-2042.2009.02405.x"},{"key":"ref1","unstructured":"2. Khedmat H, Taheri S. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD. Int. Survey. Ann Transplant. 2010;15(3):80-86."},{"key":"ref2","unstructured":"3. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc. 1969;1(1):106-112."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Allen U, Alfieri C, Preiksaitis J, et al; Canadian PTLD Workshop Group 1999. Epstein-Barr virus infection in transplant recipients: summary of a workshop on surveillance, prevention and treatment. Can J Infect Dis. 2002;13(2):89-99. doi:10.1155\/2002\/634318","DOI":"10.1155\/2002\/634318"},{"key":"ref4","unstructured":"5. Walker RC, Paya CV, Marshall WF, et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant. 1995;14(2):214-221."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Ignacak E, Sulowicz J, Giza A, Cieniawski D, Kuzniewski M, Sulowicz W. Post-transplant lymphoproliferative disorder in a patient after kidney transplant, 5-year follow-up: a case report. Transplant Proc. 2020;52(8):2517-2519. doi:10.1016\/j.transproceed.2020.02.083","DOI":"10.1016\/j.transproceed.2020.02.083"},{"key":"ref6","unstructured":"7. Khedmat H, Alavian S, Taheri S. Significance of Epstein-Barr virus infection in the outcome of renal transplant patients with lymphoproliferative disorders. Ann Transplant. 2010;15(2):40-44."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004;4(2):222-230. doi:10.1046\/j.1600-6143.2003.00325.x","DOI":"10.1046\/j.1600-6143.2003.00325.x"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Morscio J, Dierickx D, Tousseyn T. Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far? Clin Dev Immunol. 2013;2013:150835. doi:10.1155\/2013\/150835","DOI":"10.1155\/2013\/150835"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Haverkos BM, Oza VM, Johnson A, Walker J, Shana'ah A. Rare presentation of post-transplant lymphoproliferative disorder isolated to gastroesophageal junction. World J Gastrointest Oncol. 2013;5(12):230-234. doi:10.4251\/wjgo.v5.i12.230","DOI":"10.4251\/wjgo.v5.i12.230"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Oertel SH, Verschuuren E, Reinke P, et al. Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant. 2005;5(12):2901-2906. doi:10.1111\/j.1600-6143.2005.01098.x","DOI":"10.1111\/j.1600-6143.2005.01098.x"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Petrara MR, Serraino D, Di Bella C, et al. Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors. Cancer Lett. 2020;469:323-331. doi:10.1016\/j.canlet.2019.10.045","DOI":"10.1016\/j.canlet.2019.10.045"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Bishnoi R, Bajwa R, Franke AJ, et al. Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients. Exp Hematol Oncol. 2017;6:26. doi:10.1186\/s40164-017-0087-0","DOI":"10.1186\/s40164-017-0087-0"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Rencuzogullari A, Binboga S, Aytac E, Rabets J, Stocchi L, Ozuner G. Incidence, management, and risk factors for lower gastrointestinal bleeding in renal transplant recipients. Transplant Proc. 2017;49(3):501-504. doi:10.1016\/j.transproceed.2017.02.001","DOI":"10.1016\/j.transproceed.2017.02.001"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Siegel A, Boike J, Trivedi I, Yadlapati R. Posttransplant lymphoproliferative disorder of the small bowel as an unexpected cause of iron deficiency anemia decades after heart transplantation. ACG Case Rep J. 2017;4:e86. doi:10.14309\/crj.2017.86","DOI":"10.14309\/crj.2017.86"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T08:59:51Z","timestamp":1610701191000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/current\/2021\/19\/1\/0\/77\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2020.0437","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}